Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Wash-sale considerations when replacing dividend ETF protect your tax position. This guide outlines rule basics, look-back periods, and compliant practices.
13,425 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
These software stocks have surged as geopolitical tensions rise, outpacing broader tech gains and signaling a shift i...
Nebius has drawn attention with bold AI capacity announcements and aggressive revenue targets. This guide breaks down...
Citi analysts say Netflix is better positioned to lift pricing now that licensing and regulatory overhangs have eased...
A personal-finance-focused look at how the next generation must blend grit with adaptability as AI reshapes internshi...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
The SEC is exploring a proposal that could let U.S. public companies report semiannually instead of quarterly, prompt...
Lululemon has faced headwinds after a peak stretch. This article outlines whether lululemon stock recover? is feasibl...
The AI era is shifting how businesses operate and how investors pick winners. As agents arrived. stocks track emerges...
APM’s Michael Banner says HECM for Purchase has failed to take off due to industry shortcomings rather than product f...
A major alliance between Mastercard and Ripple signals a potential price move for XRP in 2026. This article breaks do...
When AI dominates headlines, investors often fear every software stock will crumble. This piece digs into whether fig...